Advertisement
Screener

Decheng Capital LLC Historic Quarter Change: USA Other Stocks, Sold Out

Decheng Capital LLC historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Decheng Capital LLC opened 3 positions, added to 4, reduced 1 and sold out of 7.

  • Q4 2025: Stock MOONLAKE IMMUNOTHERAPEUTICS; Country of operation —; Class COM; Shares before 181,600.
  • Q4 2024: Stock LONGBOARD PHARMACEUTICALS IN; Country of operation United States; Class COM; Shares before 56,350.
  • Q2 2024: Stock Alpine Immune Sciences, Inc.; Country of operation United States; Class COM; Shares before 8,317,924.
  • Q1 2024: Stock IMMUNOGEN INC; Country of operation United States; Class COM; Shares before 659,928.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 2010850), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-13); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-12); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-13); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-08); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-15); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2023-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2025MOONLAKE IMMUNOTHERAPEUTICS
CUSIP G4444C102
COM181,6000-181,600$1,302,072$0-$1,302,0722026-02-12
Q4 2024LONGBOARD PHARMACEUTICALS IN
CUSIP 54300N103
United StatesCOM56,3500-56,350$1,878,146$0-$1,878,1462025-02-14
Q2 2024Alpine Immune Sciences, Inc.
CUSIP 02083G100
United StatesCOM8,317,9240-8,317,924$329,722,507$0-$329,722,5072024-08-14
Q1 2024IMMUNOGEN INC
CUSIP 45253H101
United StatesCOM659,9280-659,928$19,566,865$0-$19,566,8652024-05-14
Q1 2024KARUNA THERAPEUTICS INC
CUSIP 48576A100
United StatesCOM47,0000-47,000$14,875,970$0-$14,875,9702024-05-14
Q1 2024ACELYRIN INC(NSM)
CUSIP 00445A100
United StatesCOM1,370,9510-1,370,951$10,227,294$0-$10,227,2942024-05-14
Q1 2024Scynexis Inc.
CUSIP 811292200
United StatesCOM NEW555,5550-555,555$1,238,888$0-$1,238,8882024-05-14

Similar Firms

Firm NameCountry13F ValueHoldings
Triasima Portfolio Management inc.Canada$0.661B137
Fulcrum Asset Management LLPUnited Kingdom$0.662B220
Optas, LLCUnited States$0.661B1,034
GLOBEFLEX CAPITAL L PUnited States$0.661B387
Heritage Investment Group, Inc.United States$0.661B123
REGATTA CAPITAL GROUP, LLCUnited States$0.661B215
Freemont Management S.A.Switzerland$0.661B136
AFFINITY WEALTH MANAGEMENT LLCUnited States$0.661B103
Arosa Capital Management LPUnited States$0.660B68
Artemis Wealth Advisors, LLCUnited States$0.662B45